首页> 美国卫生研究院文献>Critical Care >A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant

【2h】

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant

机译：一种用于治疗遗传性血管性水肿患者的急性血管性水肿发作的新颖治疗概念：使用缓激肽-B2受体拮抗剂依卡替班即使在严重的肿胀发作中也能获得多种成功的治疗方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Critical Care
作者
M Bas; J Greve; G Kojda; H Bier; T Hoffmann;
展开▼
作者单位

展开▼
年(卷),期 2006(10),Suppl 1
年度 2006
页码 P315
总页数 197
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant [J] . M Bas, J Greve, G Kojda, Critical care : . 2006,第Suppla1期

机译：一种用于治疗遗传性血管性水肿患者的急性血管性水肿发作的新颖治疗概念：使用缓激肽-B2受体拮抗剂依卡替班，即使在严重的肿胀发作中也能获得多种成功的治疗方法
2. Randomized placebo-controlled trial of the bradykinin B receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. [J] . Lumry WR, Li HH, Levy RJ, Annals of allergy, asthma, and immunology . 2011,第6期

机译：缓激肽B受体拮抗剂icatibant用于治疗遗传性血管性水肿急性发作的随机安慰剂对照试验：FAST-3试验。
3. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). [J] . Bork K, Frank J, Grundt B, The Journal of Allergy and Clinical Immunology . 2007,第6期

机译：用缓激肽受体2拮抗剂（Icatibant）治疗遗传性血管性水肿的急性水肿发作。
4. Helminths in the Treatment of Hereditary Angioedema: A Theoretical Model in Support of a Novel Therapeutic Option [C] . Donna L. Beales International Conference on Bioinformatics, Computational Biology, Genomics and Chemoinformatics . 2010

机译：蠕虫治疗遗传性血统血统：一种基于新型治疗选择的理论模型
5. Screening of natural products for their effect on kallikrein-kinin system: Potential implications in the treatment of hereditary angioedema. [D] . Madkhali, Hassan Abdu. 2015

机译：筛选天然产物对激肽释放酶激肽系统的影响：遗传性血管性水肿治疗的潜在影响。
6. Urticaria and Angioedema: 165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency [O] . Konrad Bork, Jochen Hardt 2012

机译：荨麻疹和血管性水肿：165早期与延缓治疗伊卡替班（缓激肽2受体拮抗剂）对因C1-INH缺乏而遗传性血管性水肿的患者
7. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study [O] . Michihiro Hide, Atsushi Fukunaga, Junichi Maehara, 2020

机译：减速剂的疗效，药代动力学和安全性对遗传性血统的急性发作治疗日本患者：第3期开放标签研究

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant

著录项

相似文献

相关主题

期刊订阅